Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized, Open Study on the Efficacy and Safety of the GnRH Analogue Triptorelin for HIV-1 Reservoir Reduction in ART Treated HIV-1 Infected Patients

NCT03536234 is registered in ClinicalTrials.gov with Immune System Regulation AB as lead sponsor.

NCT NCT03536234
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03536234 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized, Open Study on the Efficacy and Safety of the GnRH Analogue Triptorelin for HIV-1 Reservoir Reduction in ART Treated HIV-1 Infected Patients
Lead sponsor
Immune System Regulation AB
Phase
Phase 2
Overall status
Unknown status
Start date
September 19, 2018
Completion date
December 31, 2021
Enrollment
52 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

hiv-1-infection